I work in the Policy, Evidence and Influencing team at Breast Cancer Now.
A key area of our work is improving access to drugs. We ensure decision-makers hear the views of patients about the importance of new, clinically-effective drugs reaching people swiftly.
The National Institute of Health and Care Excellence (NICE) wants to hear our views on a new breast cancer treatment.
- Tucatinib with trastuzumab and capecitabine which is a treatment for HER2 positive secondary breast cancer after 2 or more anti-HER2 therapies
If you have experience of taking this treatment combination, you could help shape our input into NICE’s assessment on whether this treatment will be available on the NHS.
Please get in touch by Friday 2nd April via this link breastcancernow.org/about-us/tell-us-your-story